PAREXEL CLINICAL RESEARCH
Company Profile:
Company Profile: PAREXEL CLINICAL RESEARCH, Philippines
Business Type: Service Provider
PAREXEL CLINICAL RESEARCH in the Philippines operates as a prominent Contract Research Organization (CRO). It is neither a factory nor a trader. Instead, it specializes in providing comprehensive clinical development services to the global pharmaceutical, biotechnology, and medical device industries.
The company's operations in the Philippines are an integral part of its worldwide network, focusing on the execution and management of clinical trials. Key services typically include:
Clinical trial design and protocol development
Patient recruitment and retention
Clinical site management and monitoring
Data management and biostatistics
Regulatory consulting and submissions
Medical writing
Pharmacovigilance (drug safety)
PAREXEL's mission is to accelerate the development of new therapies by efficiently conducting clinical research, thereby helping clients bring innovative treatments to patients faster. Its Philippine operations contribute significantly to this global endeavor by leveraging local expertise and infrastructure to support international clinical studies.
Enterprise Products
PAREXEL CLINICAL RESEARCH in the Philippines primarily provides services related to clinical research and drug development. They do not manufacture or sell physical products. Their offerings include:
Clinical Trial Management
Clinical Monitoring
Data Management
Biostatistics
Medical Writing
Regulatory Affairs Consulting
Pharmacovigilance
Patient Recruitment and Retention Services
Site Management and Support
Quality Assurance Services
Early Phase Clinical Development Services
Late Phase Clinical Development Services
Real-World Evidence Services
Digital and Decentralized Clinical Trial Solutions
Business Registration Information:
Manager:
Phone:
E-mail:
Official Website:
Address:
U-2601-02, 26F, The Finance Centre
26th Street corner 9th Avenue
Bonifacio Global City, Taguig, 1634 Metro Manila
Philippines
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.